Highlights from the 2013 Science of Placebo thematic workshop

ecancermedicalscience

Volumn 7, Issue 1, 2013, Pages

  Annoni, Marco ^a,b,c,d  

^a UNIVERSITY OF MILAN   (Italy)

^b European School of Molecular Medicine   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d FOLSATEC   (Italy)

Author keywords

Acupuncture; Chronic pain; Clinical trial; Depression; FMRI; Pain; Parkinson; PET; Placebo; Placebo effect; Placebo response; Randomization

Indexed keywords

PLACEBO;

ANALGESIA; ARTICLE; AWARENESS; BRAIN REGION; CLINICAL PRACTICE; CLINICAL RESEARCH; DELUSION; EMPIRICAL RESEARCH; HUMAN; NEUROBIOLOGY; NOCICEPTION; PAIN; PARKINSON DISEASE; PLACEBO EFFECT; SCIENTIST; STATE DEPENDENT LEARNING; THEMATIC ANALYSIS; WORKSHOP;

EID: 84885655276     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2013.346     Document Type: Article

References (19)

1. Amanzio M and Benedetti F (1999) Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems J Neurosci 19(1) 484-94 PMID: 9870976
2. Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, Bergamasco B and Lopiano L (2004) Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus Nat Neurosci 7(6) 587-8 DOI: 10.1038/nn1250 PMID: 15146189
3. Benedetti F, Lanotte M, Colloca L, Ducati A, Zibetti M and Lopiano L (2009) Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response J Phsyiol 587 3869-83 DOI: 10.1113/jphysiol.2009.169425
4. Colloca L, Lopiano L, Lanotte M and Benedetti F (2004) Overt versus covert treatment for pain, anxiety, and Parkinson's disease Lancet Neurol 3(11) 679-84 DOI: 10.1016/S1474-4422(04)00908-1 PMID: 15488461
5. Haake M, Müller HH, Schade-Brittinger C, Basler HD, Schäfer H, Maier C, Endres HG, Trampisch HJ and Molsberger A (2007) German Acupuncture Trials (GERAC) for chronic low back pain: randomized, multicenter, blinded, parallel-group trial with 3 groups Arch Intern Med 167(17) 1892-8 DOI: 10.1001/Archinte.167.17.1892 PMID: 17893311
6. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM and Cohen JD (2004) Placebo-induced changes in MRI in the anticipation and experience of pain Science 303 Supplement 1162-7 DOI: 10.1126/science.1093065 PMID: 14976306
7. Wager TD and Fields H (2013) Placebo analgesia Textbook of Pain, ed PD Wall and R Melzack pp 362-73
8. Buhle JT, Stevens BL, Friedman JJ and Wager TD (2012) Distraction and placebo: two separate routes to pain control Psychol Sci 23(3) 246-53 DOI: 10.1177/0956797611427919 PMID: 22261568
9. Meissner K, Bingel U, Colloca L, Wager TD, Watson A and Flaten MA (2011) The placebo effect: advances from different methodological approaches J Neurosci 31(45) 16117-24 DOI: 10.1523/JNEUROSCI.4099-11.2011 PMID: 22072664 PMCID: 3242469
10. Roy M, Shohamy D and Wager TD (2012) Ventromedial prefrontal-subcortical systems and the generation of affective meaning Trends Cogn Sci 16(3) 147-56 DOI: 10.1016/j.tics.2012.01.005 PMID: 22310704 PMCID: 3318966
11. Levine JD, Gordon NC and Fields HL (1978) The mechanism of placebo analgesia Lancet 23 2(8091) 654-65 DOI: 10.1016/S0140- 6736(78)92762-9 PMID: 80579
12. Petrovic P, Kalso E, Petersson KM and Ingvar M (2002) Placebo and opioid analgesia - imaging a shared neuronal network Science 295(5560) 1737-40 DOI: 10.1126/science.1067176 PMID: 11834781
13. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ and Johnson BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration PLoS Med 5(2) e45 DOI: 10.1371/journal.pmed.0050045 PMID: 18303940 PMCID: 2253608
14. Petrovic P, Dietrich T, Fransson P, Andersson J, Carlsson K and Ingvar M (2005) Placebo in emotional processing-induced expectations of anxiety relief activate a generalized modulatory network Neuron 46(6) 957-69 PMID: 15953423
15. Schoenbaum G and Roesch M (2005) Orbitofrontal cortex, associative learning, and expectancies Neuron 47 633-63 DOI: 10.1016/j.neuron.2005.07.018 PMID: 16129393 PMCID: 2628809
16. Seymour B, O'Doherty JP, Koltzenburg M, Wiech K, Frackowiak R, Friston K and Dolan R (2005) Opponent appetitive-aversive neural processes underlie predictive learning of pain relief Nat Neurosci 8(9) 1234-40 DOI: 10.1038/nn1527 PMID: 16116445
17. Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, Kirsch I, Schyner RN, Nam BH, Nguyen LT, Park M, Rivers AL, McManus C, Kokkotou E, Drossman DA, Goldman P and Lembo AJ (2008) Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome BMJ 3;336(7651) 999-1003 DOI: 10.1136/bmj.39524.439618.25 PMID: 18390493 PMCID: 2364862
18. Wechsler ME, Kelley JM, Boyd IO, Dutile S, Marigowda G, Kirsch I, Israel E and Kaptchuk TJ (2011) Active albuterol or placebo, sham acupuncture, or no intervention in asthma N Engl J Med 14;365(2) 119-26 DOI: 10.1056/NEJMoa1103319 PMID: 21751905 PMCID: 3154208
19. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I and Lembo AJ (2010) Placebos without deception: a randomized controlled trial in irritable bowel syndrome, PLoS One 5(12) e15591 DOI: 10.1371/journal.pone.0015591